Evidence-Based Dermatology

Summary

Evidence-based Dermatology, Second Edition is a unique book in the field of clinical dermatology. Written and edited by some of the world's leading experts in evidence-based dermatology, it takes a highly evidence-based approach to the treatment of all major and many of the less common skin conditions.The toolbox at the beginning of the book explaining how to critically appraise different studies, along with the comprehensive reviewing and appraisal of evidence in the clinical chapters makes this book distinctive in its field as do the treatment recommendations which are based on the discussion of the best available evidence using a question-driven approach and a common structure on dealing with efficacy, drawbacks and implications for clinical practice.

Author Biography

Hywel Williams
Professor of Dermato-Epidemiology,Nottingham UK. Professor Williams is coordinating editor of the Cochrane Skin Group. He is also the dermatology adviser for Clinical Evidence (BMJ Publishing Group) which is distributed to 500 000 doctors in the US, available free to NHS institutions in the UK and is translated into 10 languages.
Michael Bigby
Assistant Professor of Dermatology, Harvard University Medical School and Chief of Dermatology, Harvard University Health Service. His chief teaching interest is in evidence-based dermatology. He edited a special issue of the Archives in Dermatology devoted to ebd, which has resulted in a quarterly ebd section to which he is a continuing contributor, and he has presented papers and chaired sessions on ebd at the AAD. He has played a major part in introducing the concept in the USA.
Thomas Diepgen
Professor of Dematology, University of Heidelberg, Gemany is a member of European Dermato-epidemiology network and a specialist in contact dermatitis, and occupationally and environmentally acquired conditions

Andrew Herxheimer
Cochrane UK Center is a founding member of the Cochrane Collaboration and now a editor of the Consumer and Communications Group. He is part of the Consumer Network and the Adverse Effects Methods subgroup and also works with the Cochrane skin group.
Luigi Naldi
Consultant Dermatologist at Ospedale Riunit Bergamo, Italy and a member of European Dermato-epidemiology network. He specialises in psoriasis.

Berthold Rzany IC3-Professor for Evidence Based Medicine in Dermatology, Head of the division of Evidence Based Medicine at the department of dermatology at the Humboldt-University in Berlin. His research topics include aesthetic medicine (e.g. botulinum toxin A, collagen, hyaluronic acid, polyactic acid & other injectables, middle depth peelings as well as hyperhidrosis

The concept of evidence-based. dermatology
The field and its boundaries
The rationale for evidence-based dermatology
The role of the consumer and the public in. evidence-based dermatology
The Cochrane Skin Group
The critical appraisal toolbox
Formulating well-built clinical questions
Finding the best evidence
The hierarchy of evidence
Appraising systematic reviews and meta-analyses
How to critically appraise a randomized controlled trial
How to assess the evidence concerning the safety of medical interventions
What makes a good case series?
What makes a good prevalence survey?
Critical appraisal of pharmacoeconomic studies
Applying the evidence back to the patient
The evidence
Common inflammatory skin diseases
Acne vulgaris
Papulopustular rosacea
Perioral dermatitis
Hand eczema
Atopic eczema
Seborrheic dermatitis
Psoriasis
Lichen planus
Acute urticaria
Chronic urticaria
Skin cancer, moles, and photoaging
Primary prevention of skin cancer
Do sunscreens reduce the incidence of skin cancers?
Cutaneous melanoma
Squamous cell carcinoma
Basal cell carcinoma
Primary cutaneous T-cell lymphoma
Actinic keratoses and Bowen's disease
Kaposi's sarcoma
Photoaging
Melanocytic nevi
Infective skin diseases and. exanthema. Hywel Williams and Thomas Diepgen, Editors
Local treatment for cutaneous warts
Impetigo
Athlete's foot
Onychomycosis
Tinea capitis
Deep fungal infections
Streptococcal cellulitis/erysipelas of the lower leg
Exanthematic reactions
Herpes simplex
Leprosy
Cutaneous leishmaniasis
Infestations
Scabies
Head lice
Insect bites and stings
Disorders of pigmentation
Vitiligo
Melasma
Hair problems
Male and female androgenetic alopecia
Alopecia areata
Evidence-based treatment of hirsutism
Leg ulceration
Venous ulcers
Other important skin disorders
Cutaneous lupus erythematosus
Dermatomyositis
Acquired subepidermal bullous diseases
Pemphigus
Cutaneous sarcoidosis
Erythema multiforme
Stevens-Johnson syndrome and toxic epidermal necrolysis
Focal hyperhidrosis
Polymorphic light eruption (PLE)
Infantile hemangiomas and port-wine stains
Psychocutaneous disease
Pruritus
Other skin diseases for which trials exist
The future of evidence-based
Where do we go from here?
Additional chapters and resources are published on the book's web site. (www.evidbasedderm.com)
Table of Contents provided by Publisher. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.